◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

XORTX Therapeutics Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00
Selling General And Administration 2.3M 2.2M 2.4M 1.6M
General And Administrative Expense 2.3M 2.2M 2.4M 1.6M
Research And Development 183,830 2.4M 6.8M 677,576
Depreciation And Amortization In Income Statement 117,274 139,694 58,146 14,266
Other Operating Expenses 1.5M 1.3M 1.1M 602,570
Operating Expense 4.1M 6.0M 10.3M 2.9M
Operating Income -4.1M -6.0M -10.3M -2.9M
EBIT -4.1M -6.0M -10.3M -2.9M
Interest Expense -- -- 0.00 4,391
Interest Expense Non Operating -- -- 0.00 4,391
Interest Income -- -- 101,367 --
Interest Income Non Operating -- -- 101,367 --
Net Interest Income 121,908 253,543 103,589 -4,451
Other Income Expense 683,065 3.6M 2.5M 1.3M
Special Income Charges -279,031 0.00 -926,456 -1.3M
Restructuring And Mergern Acquisition 279,031 0.00 926,456 1.3M
Gain On Sale Of Security 962,096 3.6M 3.4M 2.6M
Pretax Income -3.3M -2.2M -7.7M -1.6M
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -3.3M -2.2M -7.7M -1.6M
Net Income From Continuing Operation Net Minority Interest -3.3M -2.2M -7.7M -1.6M
Net Income Including Noncontrolling Interests -3.3M -2.2M -7.7M -1.6M
Net Income Common Stockholders -3.3M -2.2M -7.7M -1.6M
Net Income -3.3M -2.2M -7.7M -1.6M
EBITDA -4.0M -5.9M -10.2M -2.9M
Normalized EBITDA -4.7M -9.5M -12.7M -4.2M
Reconciled Depreciation 117,274 139,694 58,146 14,266
Basic EPS -1.15 -1.09 -4.71 -1.20
Diluted EPS -1.15 -1.09 -4.71 -1.20
Basic Average Shares 2.9M 2.0M 1.5M 1.1M
Diluted Average Shares 2.9M 2.0M 1.5M 1.1M
Total Unusual Items 683,065 3.6M 2.5M 1.3M
Total Unusual Items Excluding Goodwill 683,065 3.6M 2.5M 1.3M
Tax Rate For Calcs 0.00 0.00 0.00 0.00
Normalized Income -4.0M -5.8M -10.2M -2.9M
Amortization 31,070 66,632 17,077 14,266
Amortization Of Intangibles Income Statement 31,070 66,632 17,077 14,266
Depreciation Amortization Depletion Income Statement 117,274 139,694 58,146 14,266
Depreciation Income Statement 86,204 73,062 41,069 0.00
Diluted NI Availto Com Stockholders -3.3M -2.2M -7.7M -1.6M
Impairment Of Capital Assets -- -- -- 0.00
Net Income Continuous Operations -3.3M -2.2M -7.7M -1.6M
Net Non Operating Interest Income Expense 121,908 253,543 103,589 -4,451
Other Gand A 2.0M 1.9M 1.8M 1.2M
Salaries And Wages 290,670 300,390 610,512 445,789
Total Expenses 4.1M 6.0M 10.3M 2.9M
Total Other Finance Cost -121,908 -253,543 -103,589 4,451
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 2.5M 3.4M 10.4M 14.9M
Cash Cash Equivalents And Short Term Investments 2.5M 3.4M 10.4M 14.9M
Cash Equivalents 2.4M 3.4M 6.6M 0.00
Cash Financial 53,686 94,999 3.8M 14.9M
Accounts Receivable 17,637 60,711 81,752 40,654
Receivables 17,637 60,711 81,752 40,654
Prepaid Assets 185,412 236,966 379,620 1.0M
Current Assets 2.7M 4.1M 10.9M 15.9M
Gross PPE 234,930 137,932 133,621 0.00
Accumulated Depreciation -200,209 -114,005 -40,943 0.00
Net PPE 34,721 23,927 92,678 0.00
Goodwill And Other Intangible Assets 183,108 175,254 199,834 202,125
Other Intangible Assets 183,108 175,254 199,834 202,125
Total Non Current Assets 1.4M 1.4M 1.5M 1.5M
Total Assets 4.1M 5.5M 12.4M 17.4M
Current Debt And Capital Lease Obligation 38,785 11,510 66,090 --
Accounts Payable 84,020 195,814 1.3M 323,961
Payables 84,020 195,814 1.3M 323,961
Payables And Accrued Expenses 147,205 283,428 1.4M 552,948
Current Accrued Expenses 63,185 87,614 151,406 228,987
Other Current Liabilities 572,000 531,000 -- --
Current Liabilities 757,990 825,938 1.5M 552,948
Long Term Debt And Capital Lease Obligation -- 0.00 11,509 0.00
Long Term Capital Lease Obligation -- 0.00 11,509 0.00
Total Non Current Liabilities Net Minority Interest 0.00 0.00 3.9M 3.6M
Total Liabilities Net Minority Interest 757,990 825,938 5.4M 4.2M
Common Stock 18.5M 17.1M 16.5M 16.1M
Capital Stock 18.5M 17.1M 16.5M 16.1M
Retained Earnings -21.2M -17.9M -15.7M -8.0M
Gains Losses Not Affecting Retained Earnings -52,605 -52,605 -52,605 75,540
Other Equity Adjustments -52,605 -52,605 -52,605 75,540
Common Stock Equity 3.3M 4.6M 7.0M 13.2M
Stockholders Equity 3.3M 4.6M 7.0M 13.2M
Total Equity Gross Minority Interest 3.3M 4.6M 7.0M 13.2M
Total Capitalization 3.3M 4.6M 7.0M 13.2M
Net Tangible Assets 3.2M 4.5M 6.8M 13.0M
Tangible Book Value 3.2M 4.5M 6.8M 13.0M
Working Capital 1.9M 3.2M 9.4M 15.4M
Invested Capital 3.3M 4.6M 7.0M 13.2M
Total Debt 38,785 11,510 77,599 0.00
Share Issued 3.5M 2.0M 1.7M 1.4M
Ordinary Shares Number 3.5M 2.0M 1.7M 1.4M
Buildings And Improvements 211,586 114,588 114,588 0.00
Capital Lease Obligations 38,785 11,510 77,599 0.00
Current Capital Lease Obligation 38,785 11,510 66,090 0.00
Current Deferred Assets 0.00 323,441 0.00 0.00
Derivative Product Liabilities -- 531,000 3.9M 3.6M
Non Current Accounts Receivable 1.2M 1.2M 1.2M 1.3M
Other Equity Interest 6.1M 5.5M 6.2M 5.0M
Other Properties 23,344 23,344 19,033 --
Properties 0.00 0.00 0.00 0.00
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow -3.7M -6.6M -8.2M -4.8M
Cash Flow From Continuing Operating Activities -3.7M -6.6M -8.2M -4.8M
Depreciation And Amortization 117,274 139,694 58,146 14,266
Depreciation Amortization Depletion 117,274 139,694 58,146 14,266
Stock Based Compensation 122,527 120,984 487,940 396,423
Change In Working Capital 116,793 -1.0M 1.5M -1.1M
Changes In Account Receivables 43,074 21,041 -41,098 -29,383
Change In Receivables 43,074 21,041 -41,098 -29,383
Change In Payables And Accrued Expense -134,447 -1.2M 892,265 -259,323
Other Non Cash Items -- -- 3,702 59,092
Capital Expenditure -38,924 -46,363 -45,701 -31,807
Purchase Of PPE 0.00 -4,311 -19,696 0.00
Net PPE Purchase And Sale 0.00 -4,311 -19,696 0.00
Investing Cash Flow -38,924 -46,363 -45,701 -31,807
Cash Flow From Continuing Investing Activities -38,924 -46,363 -45,701 -31,807
Repayment Of Debt -69,723 -66,089 -20,410 0.00
Net Issuance Payments Of Debt -69,723 -66,089 -20,410 0.00
Issuance Of Capital Stock 3.5M 0.00 5.0M 18.1M
Net Common Stock Issuance 3.5M 0.00 5.0M 18.1M
Financing Cash Flow 2.8M -361,044 3.9M 19.4M
Cash Flow From Continuing Financing Activities 2.8M -361,044 3.9M 19.4M
Effect Of Exchange Rate Changes -35,953 4,041 -136,146 195,863
Changes In Cash -938,063 -7.0M -4.3M 14.5M
Beginning Cash Position 3.4M 10.4M 14.9M 134,516
End Cash Position 2.5M 3.4M 10.4M 14.9M
Free Cash Flow -3.7M -6.6M -8.2M -4.8M
Amortization Cash Flow 31,070 66,632 17,077 14,266
Amortization Of Intangibles 31,070 66,632 17,077 14,266
Asset Impairment Charge -- -- 0.00 0.00
Change In Prepaid Assets 208,166 142,654 622,595 -794,713
Common Stock Issuance 3.5M 0.00 5.0M 18.1M
Depreciation 86,204 73,062 41,069 --
Gain Loss On Investment Securities -756,074 -3.6M -2.5M -2.6M
Long Term Debt Payments -69,723 -66,089 -20,410 0.00
Net Foreign Currency Exchange Gain Loss 34,178 -13,634 -6,391 28,258
Net Income From Continuing Operations -3.3M -2.2M -7.7M -1.6M
Net Intangibles Purchase And Sale -38,924 -42,052 -26,005 -31,807
Net Long Term Debt Issuance -69,723 -66,089 -20,410 0.00
Net Other Financing Charges -667,883 -295,251 -1.1M -698,579
Operating Gains Losses -721,896 -3.7M -2.5M -2.6M
Proceeds From Stock Option Exercised 16,573 296.00 64.00 2.0M
Provisionand Write Offof Assets -- -- 0.00 0.00
Purchase Of Intangibles -38,924 -42,052 -26,005 -31,807
NEWS
Loading news...
TRENDING
Loading...